Clinical predictors and outcomes of patients with left ventricular thrombus following ST-segment elevation myocardial

Adam M Garber1, Robert J Mentz2, Hussein R Al-Khalidi3

  • 1Department of Internal Medicine, Virginia Commonwealth University, 1200 East Broad St., P.O. Box 980102, Richmond, VA, 23298-0102, USA. agarber@mcvh-vcu.edu.

Insights

Left ventricular thrombus (LVT) after ST-segment elevation myocardial infarction (STEMI) is predicted by higher heart rate, non-white race, heart failure severity, and LAD disease. Further research is needed to confirm if anticoagulation improves outcomes in high-risk patients.

Area of Science:

  • Cardiology
  • Clinical Medicine
  • Medical Research

Background:

  • Left ventricular thrombus (LVT) formation after ST-segment elevation myocardial infarction (STEMI) lacks well-defined contemporary predictors.
  • Understanding these predictors is crucial for risk stratification and management.

Purpose of the Study:

  • To identify independent predictors of LVT following STEMI.
  • To investigate the association between LVT and long-term mortality in STEMI patients.

Main Methods:

  • Retrospective analysis of 1734 STEMI patients undergoing echocardiography within 90 days post-STEMI (2000-2011).
  • Cox proportional hazards regression models were used to identify independent predictors of LVT.
  • Multivariable survival models assessed the association between LVT and all-cause mortality.

Main Results:

  • 4.3% of patients developed LVT.
  • Independent predictors of LVT included higher heart rate, non-white race, heart failure severity, and left anterior descending artery (LAD) disease.
  • A trend towards increased all-cause mortality was observed in patients with LVT, but it was not statistically significant.

Conclusions:

  • Higher heart rate, non-white race, heart failure severity, and LAD disease are independent predictors of LVT post-STEMI.
  • Prospective studies are warranted to evaluate the efficacy of anticoagulation in high-risk LVT patients.

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
456
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
672
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
1.7K
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
763
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
463
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
446